Zomedica Corp.
(TSX Venture Exchange : ZOM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.45%177.730.7%$1395.79m
MRKMerck & Co., Inc. 0.52%92.370.7%$1222.22m
PFEPfizer Inc. 0.69%51.010.9%$1185.38m
LLYEli Lilly & Co. 1.63%322.791.1%$1109.04m
BMYBristol-Myers Squibb Co. -0.43%78.371.0%$1099.22m
ABBVAbbVie, Inc. 2.36%156.101.9%$1012.28m
AZNAstraZeneca Plc 1.93%67.201.0%$455.37m
SGENSeagen Inc. 0.54%179.435.7%$329.39m
TPTXTurning Point Therapeutics, Inc. 0.24%75.240.0%$296.61m
GSKGSK Plc 1.06%43.810.2%$288.05m
HZNPHorizon Therapeutics Plc 0.87%82.405.4%$178.17m
NVSNovartis AG 1.02%85.030.2%$168.02m
MRTXMirati Therapeutics, Inc. 0.41%68.781.6%$163.41m
NVONovo Nordisk A/S 1.76%110.210.1%$148.10m
ALNYAlnylam Pharmaceuticals, Inc. 2.30%145.478.1%$145.14m

Company Profile

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.